glp 1 for ankylosing spondylitis Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study Biologics for Ankylosing Spondylitis: 7
Description
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
In comparison, there was no difference between 5mg of tirzepatide and 2mg of semaglutide (Wegovy)
Alternativt br en strk mobilbrowser-oplevelse levere tilsvarende kvalitet med hurtig navigation, tydelige knapper og fuld adgang til bonusser, betalinger og support uden begrnsninger
doi: 10.1016/S2213-8587(18)30104-9
